1. Home
  2. MFIC vs ALVO Comparison

MFIC vs ALVO Comparison

Compare MFIC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MidCap Financial Investment Corporation

MFIC

MidCap Financial Investment Corporation

HOLD

Current Price

$10.42

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFIC
ALVO
Founded
2004
2013
Country
United States
Luxembourg
Employees
N/A
1032
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MFIC
ALVO
Price
$10.42
$3.63
Analyst Decision
Hold
Buy
Analyst Count
7
4
Target Price
$11.25
$9.25
AVG Volume (30 Days)
1.3M
667.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.22
Revenue Next Year
N/A
$37.22
P/E Ratio
$10.50
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$9.48
$3.45
52 Week High
$13.51
$11.85

Technical Indicators

Market Signals
Indicator
MFIC
ALVO
Relative Strength Index (RSI) 45.00 32.66
Support Level $9.48 N/A
Resistance Level $11.74 $4.17
Average True Range (ATR) 0.40 0.19
MACD 0.01 -0.02
Stochastic Oscillator 63.18 24.22

Price Performance

Historical Comparison
MFIC
ALVO

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Share on Social Networks: